Biologic drugs and non-biologic complex drugs have revolutionized the treatment of many difficult-to-treat diseases including cancer, multiple sclerosis, and chronic iron deficiency.
Scott Kolodny
Advertisement
Articles by Scott Kolodny
Advertisement
Latest Updated Articles
- Patient Safety Considerations for Follow-On Non-Biologic Complex Drugs
Published: March 30th 2015 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: AI, Equity, and Innovation Drive Clinical Research Forward
2
Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer
3
Reducing Site Burden Through Better Technology Integration in Clinical Trials
4
ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
